Has it become vogue to leverage other regulators’ authorizations for medical device market access?
Learn about the European Database on Medical Devices (EUDAMED) compliance requirements for medical device and in-vitro diagnostics (IVD) companies in Europe.
The US FDA issued a notice identifying how the agency plans to transition the guidance documents related to COVID-19 once the public health emergency (PHE) ends.
European Commissioners have published a new Q&A resource document covering recent amendments to European Medical Devices Regulation (MDR) and In Vitro Diagnostic Medical Devices Regulation (IVDR) requirements.
The amendment addressing the extension of the MDR transitional periods and abandoning the “sell-off” provisions has gone into force.
Key questions and answers on new amendment extending European MDR transition period
Vietnam Ministry of Health extends transition periods for higher-risk medical devices
The US FDA has issued a number of updates, including revised emergency use authorizations (EUA) for surgical masks, extended MDSAP temporary audit measures, and more.
Two Delegated Regulations from the European Commission will decrease frequency of Notified Body re-assessments under MDR, IVDR
European Council vote means longer MDR transition timelines for qualifying medical devices